{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:19:57Z","timestamp":1792113597572,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL75092"],"award-info":[{"award-number":["R01 HL75092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["Trans-Atlantic Network Grant"],"award-info":[{"award-number":["Trans-Atlantic Network Grant"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"\"la Caixa\" Foundation","doi-asserted-by":"publisher","award":["AtheroConvergence, HR20-00075"],"award-info":[{"award-number":["AtheroConvergence, HR20-00075"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["23POST1026109"],"award-info":[{"award-number":["23POST1026109"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-024-00522-z","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:02:55Z","timestamp":1725444175000},"page":"1035-1048","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Endothelial \u03b3-protocadherins inhibit KLF2 and KLF4 to promote atherosclerosis"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4415-2677","authenticated-orcid":false,"given":"Divyesh","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Coon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-517X","authenticated-orcid":false,"given":"Hanqiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8052-684X","authenticated-orcid":false,"given":"Ziyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Babar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-6767","authenticated-orcid":false,"given":"Pablo","family":"Fernandez-Tussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-7837","authenticated-orcid":false,"given":"Nikhil","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James G.","family":"Traylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Wayne","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-1924","authenticated-orcid":false,"given":"Carlos","family":"Fernandez-Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephania","family":"Libreros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2071-1243","authenticated-orcid":false,"given":"Martin A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"522_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1083\/jcb.201603106","volume":"214","author":"N Baeyens","year":"2016","unstructured":"Baeyens, N. et al. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia. J. Cell Biol. 214, 807\u2013816 (2016).","journal-title":"J. Cell Biol."},{"key":"522_CR2","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1093\/eurheartj\/ehu353","volume":"35","author":"BR Kwak","year":"2014","unstructured":"Kwak, B. R. et al. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur. Heart J. 35, 3013\u20133020 (2014).","journal-title":"Eur. Heart J."},{"key":"522_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1074248414555005","volume":"20","author":"I Andreou","year":"2015","unstructured":"Andreou, I. et al. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress. J. Cardiovasc. Pharmacol. Ther. 20, 261\u2013275 (2015).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"522_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2015.03.017","volume":"240","author":"MI Papafaklis","year":"2015","unstructured":"Papafaklis, M. I. et al. Effect of the local hemodynamic environment on the de novo development and progression of eccentric coronary atherosclerosis in humans: insights from PREDICTION. Atherosclerosis 240, 205\u2013211 (2015).","journal-title":"Atherosclerosis"},{"key":"522_CR5","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2174\/1568026623666230329085631","volume":"23","author":"G Siasos","year":"2023","unstructured":"Siasos, G. et al. The role of shear stress in coronary artery disease. Curr. Top. Med. Chem. 23, 2132\u20132157 (2023).","journal-title":"Curr. Top. Med. Chem."},{"key":"522_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/ATVBAHA.108.165811","volume":"28","author":"JO Fledderus","year":"2008","unstructured":"Fledderus, J. O. et al. KLF2 primes the antioxidant transcription factor Nrf2 for activation in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 1339\u20131346 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"522_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrm2596","volume":"10","author":"C Hahn","year":"2009","unstructured":"Hahn, C. & Schwartz, M. A. Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 10, 53\u201362 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"522_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1089\/ars.2010.3647","volume":"15","author":"L Nayak","year":"2011","unstructured":"Nayak, L., Lin, Z. & Jain, M. K. \u2018Go with the flow\u2019: how Kruppel-like factor 2 regulates the vasoprotective effects of shear stress. Antioxid. Redox Signal. 15, 1449\u20131461 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"522_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1089\/ars.2010.3679","volume":"15","author":"P Nigro","year":"2011","unstructured":"Nigro, P., Abe, J.-I. & Berk, B. C. Flow shear stress and atherosclerosis: a matter of site specificity. Antioxid. Redox Signal. 15, 1405\u20131414 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"522_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-386930-2.00007-0","volume":"124","author":"P Novodvorsky","year":"2014","unstructured":"Novodvorsky, P. & Chico, T. J. A. The role of the transcription factor KLF2 in vascular development and disease. Prog. Mol. Biol. Transl. Sci. 124, 155\u2013188 (2014).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"522_CR11","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.20031132","volume":"199","author":"S SenBanerjee","year":"2004","unstructured":"SenBanerjee, S. et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199, 1305\u20131315 (2004).","journal-title":"J. Exp. Med."},{"key":"522_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fcvm.2018.00006","volume":"5","author":"DR Sweet","year":"2018","unstructured":"Sweet, D. R., Fan, L., Hsieh, P. N. & Jain, M. K. Kr\u00fcppel-like factors in vascular inflammation: mechanistic insights and therapeutic potential. Front. Cardiovasc. Med. 5, 6 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"522_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-021-00690-5","volume":"6","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal. Transduct. Target. Ther. 6, 266 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"522_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/biomedicines10020254","volume":"10","author":"SA Dabravolski","year":"2022","unstructured":"Dabravolski, S. A. et al. The role of KLF2 in the regulation of atherosclerosis development and potential use of KLF2-targeted therapy. Biomedicines 10, 254 (2022).","journal-title":"Biomedicines"},{"key":"522_CR15","doi-asserted-by":"publisher","first-page":"e202109144","DOI":"10.1083\/jcb.202109144","volume":"221","author":"BG Coon","year":"2022","unstructured":"Coon, B. G. et al. A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells. J. Cell Biol. 221, e202109144 (2022).","journal-title":"J. Cell Biol."},{"key":"522_CR16","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1161\/ATVBAHA.114.303428","volume":"34","author":"J Abe","year":"2014","unstructured":"Abe, J. & Berk, B. C. Novel mechanisms of endothelial mechanotransduction. Arterioscler. Thromb. Vasc. Biol. 34, 2378\u20132386 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1242\/dev.090621","volume":"140","author":"WV Chen","year":"2013","unstructured":"Chen, W. V. & Maniatis, T. Clustered protocadherins. Development 140, 3297\u20133302 (2013).","journal-title":"Development"},{"key":"522_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fnmol.2020.00117","volume":"13","author":"A Pancho","year":"2020","unstructured":"Pancho, A., Aerts, T., Mitsogiannis, M. D. & Seuntjens, E. Protocadherins at the crossroad of signaling pathways. Front. Mol. Neurosci. 13, 117 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"522_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.gde.2020.05.041","volume":"65","author":"E Flaherty","year":"2020","unstructured":"Flaherty, E. & Maniatis, T. The role of clustered protocadherins in neurodevelopment and neuropsychiatric diseases. Curr. Opin. Genet. Dev. 65, 144\u2013150 (2020).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"522_CR20","doi-asserted-by":"publisher","first-page":"587819","DOI":"10.3389\/fnins.2020.587819","volume":"14","author":"Z Jia","year":"2020","unstructured":"Jia, Z. & Wu, Q. Clustered protocadherins emerge as novel susceptibility loci for mental disorders. Front. Neurosci. 14, 587819 (2020).","journal-title":"Front. Neurosci."},{"key":"522_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","volume":"112","author":"S Sen-Banerjee","year":"2005","unstructured":"Sen-Banerjee, S. et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112, 720\u2013726 (2005).","journal-title":"Circulation"},{"key":"522_CR22","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1172\/JCI66056","volume":"122","author":"G Zhou","year":"2012","unstructured":"Zhou, G. et al. Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J. Clin. Invest. 122, 4727\u20134731 (2012).","journal-title":"J. Clin. Invest."},{"key":"522_CR23","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1242\/dev.027912","volume":"135","author":"JL Lefebvre","year":"2008","unstructured":"Lefebvre, J. L., Zhang, Y., Meister, M., Wang, X. & Sanes, J. R. \u03b3-Protocadherins regulate neuronal survival but are dispensable for circuit formation in retina. Development 135, 4141\u20134151 (2008).","journal-title":"Development"},{"key":"522_CR24","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1242\/dev.026807","volume":"135","author":"T Prasad","year":"2008","unstructured":"Prasad, T., Wang, X., Gray, P. A. & Weiner, J. A. A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-\u03b3 gene cluster. Development 135, 4153\u20134164 (2008).","journal-title":"Development"},{"key":"522_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)01090-5","volume":"36","author":"X Wang","year":"2002","unstructured":"Wang, X. et al. Gamma protocadherins are required for survival of spinal interneurons. Neuron 36, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"522_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1073\/pnas.0407931101","volume":"102","author":"JA Weiner","year":"2005","unstructured":"Weiner, J. A., Wang, X., Tapia, J. C. & Sanes, J. R. Gamma protocadherins are required for synaptic development in the spinal cord. Proc. Natl Acad. Sci. USA 102, 8\u201314 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"522_CR27","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCRESAHA.114.302937","volume":"114","author":"MM Bj\u00f8rklund","year":"2014","unstructured":"Bj\u00f8rklund, M. M. et al. Induction of atherosclerosis in mice and hamsters without germline genetic engineering. Circ. Res. 114, 1684\u20131689 (2014).","journal-title":"Circ. Res."},{"key":"522_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.tips.2022.06.009","volume":"43","author":"I Ilyas","year":"2022","unstructured":"Ilyas, I. et al. Mouse models of atherosclerosis in translational research. Trends Pharmacol. Sci. 43, 920\u2013939 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"522_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang, N. et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524\u2013528 (2012).","journal-title":"Nature"},{"key":"522_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood.2022019145","volume":"142","author":"S Libreros","year":"2023","unstructured":"Libreros, S., Nshimiyimana, R., Lee, B. & Serhan, C. N. Infectious neutrophil deployment is regulated by resolvin D4. Blood 142, 589\u2013606 (2023).","journal-title":"Blood"},{"key":"522_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"522_CR32","doi-asserted-by":"publisher","first-page":"9313","DOI":"10.1074\/jbc.M412909200","volume":"280","author":"IG Haas","year":"2005","unstructured":"Haas, I. G., Frank, M., V\u00e9ron, N. & Kemler, R. Presenilin-dependent processing and nuclear function of \u03b3-protocadherins. J. Biol. Chem. 280, 9313\u20139319 (2005).","journal-title":"J. Biol. Chem."},{"key":"522_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"SJ Bray","year":"2006","unstructured":"Bray, S. J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678\u2013689 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"522_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01742-7","volume":"8","author":"JS Fang","year":"2017","unstructured":"Fang, J. S. et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149 (2017).","journal-title":"Nat. Commun."},{"key":"522_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong, P. et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal. Transduct. Target. Ther. 7, 131 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"522_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01741-8","volume":"8","author":"JJ Mack","year":"2017","unstructured":"Mack, J. J. et al. NOTCH1 is a mechanosensor in adult arteries. Nat. Commun. 8, 1620 (2017).","journal-title":"Nat. Commun."},{"key":"522_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature24998","volume":"552","author":"WJ Polacheck","year":"2017","unstructured":"Polacheck, W. J. et al. A non-canonical Notch complex regulates adherens junctions and vascular barrier function. Nature 552, 258\u2013262 (2017).","journal-title":"Nature"},{"key":"522_CR38","doi-asserted-by":"publisher","first-page":"H1403","DOI":"10.1152\/ajpheart.00002.2021","volume":"320","author":"KS Park","year":"2021","unstructured":"Park, K. S., Schecterson, L. & Gumbiner, B. M. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin. Am. J. Physiol. Heart Circ. Physiol. 320, H1403\u2013H1410 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"522_CR39","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/labinvest.2017.47","volume":"97","author":"S Kumar","year":"2017","unstructured":"Kumar, S., Kang, D. W., Rezvan, A. & Jo, H. Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation. Lab. Invest. 97, 935\u2013945 (2017).","journal-title":"Lab. Invest."},{"key":"522_CR40","doi-asserted-by":"publisher","first-page":"H1535","DOI":"10.1152\/ajpheart.00510.2009","volume":"297","author":"D Nam","year":"2009","unstructured":"Nam, D. et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 297, H1535\u2013H1543 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"522_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tips.2019.02.004","volume":"40","author":"N Niu","year":"2019","unstructured":"Niu, N., Xu, S., Xu, Y., Little, P. J. & Jin, Z.-G. Targeting mechanosensitive transcription factors in atherosclerosis. Trends Pharmacol. Sci. 40, 253\u2013266 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"522_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11305","volume":"488","author":"JL Lefebvre","year":"2012","unstructured":"Lefebvre, J. L., Kostadinov, D., Chen, W. V., Maniatis, T. & Sanes, J. R. Protocadherins mediate dendritic self-avoidance in the mammalian nervous system. Nature 488, 517\u2013521 (2012).","journal-title":"Nature"},{"key":"522_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2015.09.026","volume":"163","author":"R Rubinstein","year":"2015","unstructured":"Rubinstein, R. et al. Molecular logic of neuronal self-recognition through protocadherin domain interactions. Cell 163, 629\u2013642 (2015).","journal-title":"Cell"},{"key":"522_CR44","doi-asserted-by":"publisher","first-page":"590144","DOI":"10.3389\/fphar.2020.590144","volume":"11","author":"L Gabbert","year":"2020","unstructured":"Gabbert, L., Dilling, C., Meybohm, P. & Burek, M. Deletion of protocadherin gamma C3 induces phenotypic and functional changes in brain microvascular endothelial cells in vitro. Front. Pharmacol. 11, 590144 (2020).","journal-title":"Front. Pharmacol."},{"key":"522_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/1673-5374.343896","volume":"18","author":"V Kaupp","year":"2023","unstructured":"Kaupp, V., Blecharz-Lang, K. G., Dilling, C., Meybohm, P. & Burek, M. Protocadherin gamma C3: a new player in regulating vascular barrier function. Neural Regen. Res. 18, 68\u201373 (2023).","journal-title":"Neural Regen. Res."},{"key":"522_CR46","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"522_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/2045-824X-6-7","volume":"6","author":"CW Ni","year":"2014","unstructured":"Ni, C. W., Kumar, S., Ankeny, C. J. & Jo, H. Development of immortalized mouse aortic endothelial cell lines. Vasc. Cell 6, 7 (2014).","journal-title":"Vasc. Cell"},{"key":"522_CR48","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.cub.2017.06.020","volume":"27","author":"DE Conway","year":"2017","unstructured":"Conway, D. E. et al. VE-cadherin phosphorylation regulates endothelial fluid shear stress responses through the polarity protein LGN. Curr. Biol. 27, 2219\u20132225 (2017); erratum 27, 2727 (2017).","journal-title":"Curr. Biol."},{"key":"522_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/dvdy.20643","volume":"235","author":"JA Alva","year":"2006","unstructured":"Alva, J. A. et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235, 759\u2013767 (2006).","journal-title":"Dev. Dyn."},{"key":"522_CR50","first-page":"886","volume":"119","author":"TA Seimon","year":"2009","unstructured":"Seimon, T. A. et al. Macrophage deficiency of p38\u03b1 MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J. Clin. Invest. 119, 886\u2013898 (2009).","journal-title":"J. Clin. Invest."},{"key":"522_CR51","doi-asserted-by":"publisher","first-page":"e021160","DOI":"10.1161\/JAHA.121.021160","volume":"10","author":"M Budatha","year":"2021","unstructured":"Budatha, M., Zhang, J. & Schwartz, M. A. Fibronectin-mediated inflammatory signaling through integrin \u03b15 in vascular remodeling. J. Am. Heart Assoc. 10, e021160 (2021).","journal-title":"J. Am. Heart Assoc."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00522-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T18:12:30Z","timestamp":1726251150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00522-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1038\/s44161-024-00522-z","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A.S. and D.J. are listed as inventors in a US Provisional Patent Application no. 63\/621,466 filed by Yale University for inhibitors of Pcdhga9. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}